Clinical Trial Update: A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy of tigilanol tiglate directly in head and neck cancer; the trial is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• tigilanol tiglate (tigilanol tiglate)

Snippet

Sponsor: QBiotics Group Limited | Conditions: Head and Neck Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING